When the Government of India announced Biopharma SHAKTI in the Union Budget 2026 - a ₹10,000 crore national investment to strengthen India's biologics and biosimilars manufacturing ecosystem - it was…
Scale-up is the moment a biosimilar program starts feeling real. Moving from a 10L bench-scale fermentation to a 200L pilot run is a tangible sign that the program is progressing.…
Bevacizumab Biosimilar Development Bevacizumab is one of the more commercially significant biologics in India's biosimilar pipeline right now. Several companies are at different stages of development for oncology and ophthalmology…
Insights from recent customer interactions with leading pharmaceutical manufacturersIntroductionThis week, we had conversations with QC and R&D leadership from leading biopharma companies across India.The conversation wasn't about marketing our products.…
Inside our exclusive roadshow at one of India's premier drug discovery institutions On 13th May, 206, deNOVO Biolabs was on the ground at CSIR-Central Drug Research Institute (CDRI), Lucknow - one of…
Inside deNOVO Biolabs' COVID-Era Supply Mission In 2020, the global life sciences industry faced a supply chain crisis it had never rehearsed for. COVID-19 didn't just disrupt commercial operations -…
Key Findings at a Glance Study Objective: Evaluate sensitivity and clinical performance of deNOVO's 20X High Sensitive TMB Substrate as an alternative to imported productsValidation Partner: C-CAMP InDx Centre of Excellence in…
Biosimilar QC teams run the same problem every week. Complex in-process samples carry proteins, salts, and debris that destroy qPCR sensitivity. You add the sample straight to the reaction and…
What does it mean for EV Research in India? EVOLVE 2026 brought together India's extracellular vesicle research community at ILS, Bhubaneswar this April. Three days of sessions made one thing…
Table of Contents DNA Contamination Risks of residual Host Cell DNA FDA, EMA and CDSCO Requirements Detection Methods DNA HCP ELISA Common Mistakes in DNA Contamination Control 1. DNA Contamination…
Tuberculosis (TB) remains one of the most persistent infectious diseases globally.Despite decades of research and medical advancements, TB continues to impact millions of lives each year. According to the World…
Contents How HCP Testing affects Biosimilar Development? Generic vs Process-Specific HCP Assays Key Selection Criteria for E. Coli HCP ELISA Kits Sensitivity Requirements for Regulatory Compliance Supply Chain Considerations for…
